WebJun 2, 2024 · Sorrento is also developing potential antiviral therapies and vaccines against coronaviruses, including COVIGUARD™, COVI-AMG™, COVISHIELD™, Gene-MAb™, COVI-MSC™ and COVIDROPS™; and diagnostic test solutions, including COVITRACK™, COVISTIX™ and COVITRACE™. WebCoviTrack. CoviTrack (hackathon project) is a COVID-19 tracker app which displays the latest COVID-19 numbers, including Cases, Recoveries, and Vaccination Numbers, …
Sorrento Announces Addition of COVI-STIX™ (Covid-19 Virus
WebJun 22, 2024 · These include highly sensitive, simple, and low-cost diagnostics (COVISTIX, COVITRACK), potent neutralizing antibodies (COVI-AMG and COVIDROPS, which are … WebApr 23, 2024 · April 23, 2024. The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic: As … edexcel biology gcse bitesize
Sorrento Announces It Has Submitted an Emergency …
WebDec 7, 2024 · Sorrento is also developing potential antiviral therapies and vaccines against coronaviruses, including Abivertinib, COVI-AMG™, COVISHIELD™, COVI-MSC™ and COVIDROPS™; and diagnostic test solutions, including COVITRACK™ and COVISTIX™. WebNov 1, 2024 · Socazolimab is an anti-PD-L1 antibody licensed from Sorrento for the Greater China Territory by Lee’s Pharma. China National Medical Products Administration (NMPA) accepted the filing of socazolimab for the cervical cancer indication.; SAN DIEGO, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, "Sorrento") … WebJan 20, 2024 · Spike protein binding assays and neutralization assays using viruses representing all known SARS-CoV-2 variants of concern (VOCs) have been completed with STI-9167, and this nAb was observed to bind with high affinity and provide highly potent neutralizing activity (Omicron IC 50 = 25 ng/ml). Of noted significance, STI-9167 is … edexcel biology past papers 2021